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Abstract – (less than 150 words) 34 
 35 
Aspergillus fumigatus remains a major respiratory pathogen in birds, but diagnosis is still 36 
difficult. We challenged different groups of few-days-old turkeys via intratracheal 37 
aerosolisation of increasing concentrations (105 up to 108) of conidia using a MicroSprayer® 38 
device. The fungal burden was assessed by real-time PCR, galactomannan dosage, CFU 39 
counting and histopathological evaluation in order to provide a comparison of these results 40 
within each inoculum groups. A significant mortality occurring in the first 96 hours after 41 
inoculation was only observed with the highest inoculum dose. Culture counts, GM index 42 
and qPCR results on one hand and inoculum size on the other hand appeared to be clearly 43 
correlated. The mean fungal burden detected by qPCR was 1.3 log10 units higher than mean 44 
values determined by CFU measurement. The new model and the markers will be used for 45 
the evaluation of the efficacy of antifungal treatments that could be applied in poultry farms. 46 
 47 
 48 
 49 
 50 
Keywords (Up to 10) 51 
Turkey, lung, aspergillosis, Aspergillus fumigatus, model, real-time PCR, galactomannan, 52 
culture  53 
 54 
 55 
1. Introduction 56 
Aspergillosis is the most severe fungal disease in birds involving thermophilic mold species 57 
belonging to the genus Aspergillus, among which A. fumigatus is by far the most prevalent 58 
causative agent. In poultry production and more specifically in turkeys’ fast-growing or 59 
breeding flocks, this opportunistic infection induces severe economic losses. Generally 60 
confined to the lower respiratory tract in acute cases affecting young birds, lesions may 61 
extend to many other organs via secondary haematogenous dissemination or contiguous 62 
infection. The small diameter of conidia allow them, once inhaled, to be deposited directly 63 
deep within the respiratory system particularly in posterior air sacs. Therefore, primary 64 
colonization occurs in an optimal environment for germination and mycelium growth of 65 
Aspergillus molds. Considering the physiological specific aspects of their highly efficient 66 
respiratory tract and the lack of efficient treatments on declared aspergillosis, the 67 
development of avian models is absolutely necessary to acquire a comprehensive knowledge 68 
of the physiopathology of a disease which may be responsible for high rates of morbidity 69 
and mortality, poor performances and subsequent economic losses in poultry farms [1, 2]. 70 
Numerous vertebrate models of this disease have been successively developed to study 71 
various aspects of the fungal development in the host, the subsequent immune response and 72 
to test antifungal drug efficacy. In contrast to rodents or rabbits experimental models, 73 
immune modulation is not a necessary prerequisite in avian challenge models [1]. 74 
Aspergillosis is readily induced in healthy birds by inhalation of aerosolized conidia in 75 
turkeys [3] or chickens [4], intravenous challenge in turkeys [5], intratracheal route in 76 
starlings [6], Japanese quails [7, 8, 9], rock pigeons and gyr-falcon hybrids [10] or by 77 
transcutaneous inoculation into air sacs in turkeys [11] or racing pigeons [12]. Besides 78 
mortality or clinical signs, the monitoring of host-pathogen interactions following 79 
experimental challenge in birds rely on gross lesions and histopathological evidences [13], 80 
completed with either the detection of markers of the fungal extension [1] or the 81 
quantification of the inflammatory response [7]. Since many years now, non-culture based 82 
methods either used alone or in combination have been targeted to Aspergillus DNA by real- 83 
time PCR or cell-wall antigens in different tissues or fluids to establish a rapid diagnosis of 84 
invasive aspergillosis in humans [14] or to monitor experimental disease in several rodents 85 
models [15, 16, 17, 18, 19]. Dosages of galactomannan or 1,3-β-D-glucans have also been 86 
tested in different bird species suffering aspergillosis [20], in turkeys following experimental 87 
infection [21] and recently on field cases affecting commercial broiler chickens and turkeys 88 
[22]. 89 
 Our goal was to validate an accurate model of acute aspergillosis in intratracheally-90 
challenged turkeys. Non-culture-based methods and quantitative culture were compared to 91 
assess the fungal burden in lungs. In further investigations this original model may be used 92 
to test antifungal treatments in poultry. 93 
 94 
2. Materials and methods 95 
 96 
2.1. Aspergillus fumigatus strain, mycological cultures and preparation of the inoculum 97 
Aspergillus fumigatus strain CBS 144.89 was used for all experiments. This strain was 98 
initially isolated from a human patient with invasive aspergillosis in France and obtained 99 
from the Centraalbureau voor Schimmelculture (CBS), Utrecht, The Netherlands. All 100 
mycological cultures were done on malt agar plates supplemented with chloramphenicol (50 101 
mg/L) and incubated at 37°C till 10 days depending on the fungal growth and species. To 102 
prepare the inoculum, the strain was grown for 10 days at 37°C. Conidia were subsequently 103 
harvested by flooding the plates with sterile phosphate-buffered saline (PBS) containing 104 
0.01% (vol/vol) Tween 20 (PBST). The conidia were concentrated by centrifugation (at 105 
3500 g for 30 min) and counted using a Malassez counting chamber. 106 
 107 
2.2. Animals and housing conditions 108 
Conventional male turkeys (Le Sayec, Caudan, France) of 1-day-old with an average weight 109 
of 65 to 70 g were used. Groups of approximately 20 birds were housed in minimum 2 m² 110 
cages on wood chips litter, in the biosafety 3 level sector of the animal facility of the 111 
veterinary college of Alfort, France. Animals had permanent access to fresh commercial 112 
poultry starter (Versela-Laga) and water. Photoperiod as ambient temperature was regulated 113 
and two infrared lamps provided additional heat during all the experiment.  114 
 115 
2.3. Environmental contamination assessment 116 
The fungal contamination of the environment was assessed before and during the 117 
experiments by regular sampling of conidia by sedimentation on two opened plates placed in 118 
each cage for 30 min. In parallel, 1 g of litter and feedstuff were sampled and mixed in 45 119 
mL PBST from which 100 µl was seeded on agar plates. 120 
 121 
2.4. Nebulizer system and intratracheal challenge 122 
Two sets of experimental infections were conducted in the same conditions. For the first 123 
experiment, 36 seven-days-old turkeys were inoculated (day 0) with different concentrations 124 
of A. fumigatus (12 birds per inoculum): 105, 106 or 107 conidia per bird (groups named 125 
Inoc5, Inoc6 and Inoc7, respectively). Nine turkeys were inoculated with PBST as negative 126 
control. In the second experiment, 12 five-days-old turkeys were inoculated with 108 conidia 127 
(Inoc8) and 7 turkeys were inoculated with PBST. Two birds of each group were 128 
anesthetized immediately after inoculation in order to check the contamination level of 129 
lungs. 130 
Turkeys were anesthetized by inhalation of 5 % isoflurane (Aerrane; Baxter) in oxygen 131 
and inoculated with 100 µL of A. fumigatus suspension (or PBST) using a stainless steel 19 132 
gauge atomizer (Microsprayer IA-1B®, Penn Century, Philadelphia, PA, USA) inserted into 133 
the trachea under visual control. No intra-operative deaths or delayed recovery (less than 2 134 
min after inoculation) were observed. Birds were monitored at least twice daily and every 135 
signs of morbidity or mortalities were recorded.  136 
All animal research procedures were approved by the regional ethics committee for 137 
animal experimentation at the veterinary college of Alfort.  138 
 139 
2.5. Sample collection 140 
Targeted organs of the respiratory tract from all dead and euthanized animals were removed 141 
aseptically under laminar flow hood. The trachea and left thoracic air sac were sampled with 142 
a sterile swab. The left lungs were collected for histology and the right lungs were used for 143 
fungal culture, real time PCR and galactomannan dosage.  144 
 145 
2.6. Histological evaluation 146 
Tissues collected for histology were immediately fixed in 10% neutral buffered formalin and 147 
dehydrated. Paraffin wax-embedded specimens were sectioned at 4 µm and stained with 148 
hematoxylin-eosin-saffron (HES) to evaluate the inflammatory response. Periodic acid 149 
Schiff (PAS) and Grocott-Gomori methenamine-silver stains (MS) were used to visualize 150 
Aspergillus in lesions. A blind reading of 1 up to 10 slides per selected turkey of each group 151 
was conducted to evaluate the intensity of microscopic lesions. 152 
 153 
2.7. Fungal culture of respiratory organs 154 
The right lungs were weighed and grinded with a homogenizer of tissue (Bio-Gen PRO200 155 
Homogenizer, Pro Scientific, Oxford CT, USA) in 6 mL of PBS containing 0.01% (vol/vol) 156 
Tween 20. 100 µL of the primary lung homogenates were immediately used for fungal 157 
culture, the rest was frozen at -20°C until use.  158 
 Dilutions of primary lung homogenates and swabs of trachea and air sac were seeded 159 
on malt chloramphenicol agar plates and incubated at 37°C. The count of A. fumigatus 160 
colonies (CFU) were assessed 1 and 2 days after plate inoculation.  161 
 162 
2.8. Assessment of conidial equivalent by real time PCR 163 
The primary lung homogenates were subjected to a secondary homogenization step. 500 µL 164 
of lung homogenate was transferred to a sterile 2 mL screw-cap centrifuge tube containing 165 
0.5 mm-diameter glass beads (Biospec, Bartlesville, USA) and placed in a MagNa Lyser 166 
homogenizer (Roche, Meylan, France) for 3 bursts of 30 s at 3500 rpm with incubation on 167 
ice between bursts. The secondary lung homogenate was collected by centrifugation at 800 g 168 
for 5 min at 4°C and 100 µL of this homogenate was directly used for DNA extraction with 169 
the QIAamp DNA Mini Kit (Qiagen, Courtabeouf, France) according to the manufacturer’s 170 
directions. Fungal DNA and secondary homogenate were stored at -20°C until use. Real-171 
time TaqMan PCR quantified the amount of A. fumigatus cell nuclei by targeting the single-172 
copy FKS gene and the multi-copy gene encoding the 28S rRNA. The sequences of the FKS 173 
primers were previously reported [23]: sense amplification primer, AFKS1 (5’-GCC TGG 174 
TAG TGA AGC TGA GCG T-3’), antisens amplification primer, AFKS2 (5’-CGG TGA 175 
ATG TAG GCA TGT TGT CC-3’) and the hybridization FKS probe (5’-6-FAM-TCA CTC 176 
TCT ACC CCC ATG CCC GAG CC-BHQ1-3’). The 28S primers were reported by Challier 177 
et al. [24]: 28S-466 (5’-CTC GGA ATG TAT CAC CTC TCG G-3’) and 28S-533 (5’-TCC 178 
TCG GTC CAG GCA GG-3’) and the hybridization 28S probe (5’-6-FAM-TGT CTT ATA 179 
GCC GAG GGT GCA ATG CG- TAMRA-3’). 180 
A standard curve was established with DNA samples extracted from uninfected lungs of 181 
turkeys inoculated with different doses of A. fumigatus conidia (from 102 to 108 conidia) and 182 
allowed us to quantify the Aspergillus DNA in the organs by calculating conidial equivalents 183 
(CE) [15]. DNA samples were analysed in duplicate by using the LightCycler® 480 184 
detection system (Roche, Meylan, France). The reaction mixture consisted in 5 µL of DNA, 185 
900 or 500 nM sense and antisens primers from FKS or 28S targets, 200 nM FKS probe or 186 
250 nM 28S probe and LightCycler® 480 Probes Master 2x (Roche, Meylan, France). All 187 
assays were run under the following conditions: 50°C for 2 min, 95°C for 10 min, then 50 188 
cycles of 15 s at 95°C and 1 min at 65°C or 60°C respectively for FKS or 28S primers. 189 
 190 
2.9. Galactomannan (GM) quantity assessment 191 
500 µL of primary lung homogenates were centrifuged at 2,300 g for 5 min and the 192 
supernatant was placed into a fresh tube. Lung supernatants (300 µl) were used for GM 193 
determination with the Platelia GM-EIA kits (Bio-Rad Laboratories) according to the 194 
manufacturer’s directions. The minimum and maximum thresholds of DO detected by the 195 
ELISA reader (Biorad PR1300) ranged between 0 and 3 Abs. A 1:100 dilution of lung 196 
homogenates was realized for all groups and a 1:1000 dilution for the Inoc8 group in order 197 
to avoid the saturation of the signal detected in some crude lung homogenates.  198 
 199 
2.10. Genotyping of Aspergillus fumigatus isolates 200 
A subset of strains recovered either from the environment or from internal organs was 201 
collected and genotyped by Multi Locus VNTR Analysis [25]. 202 
 203 
2.11. Statistical analyses 204 
Statistical analyses were performed with the JMP 10.0 software. A log rank t test has been 205 
used to analyse the survival of birds and to evaluate the effect of the inoculum dose on 206 
mortality. A nonparametric one-way analysis of variance, Wilcoxon test, linear regression 207 
models and Spearman’s rank correlation were performed for multiple comparisons and to 208 
evaluate the relationship between the different biomarkers (log10 CFU/g of lung, log10 CE/g 209 
of lung and the GM index) and the inoculum doses. 210 
 211 
3. Results 212 
 213 
3.1. Body weight, clinical signs and mortality 214 
A dose dependent response was observed concerning weight gain evolution when inoculated 215 
turkeys were compared to non-challenged birds in both sets. If birds from Inoc5 and Inoc6 216 
were not affected by Aspergillus challenge, growth average of birds exposed to higher 217 
concentrations (Inoc7 and Inoc8) decreased significantly as soon as 2 days post inoculation 218 
(figure 1). 219 
No clinical signs or mortality were observed in non-challenged turkeys and Inoc5. 220 
The clinical signs observed in turkeys of Inoc6, Inoc7 and Inoc8 included lethargy, ruffled 221 
feathers, progressive weight loss and respiratory distress such as open-mouthed breathing 222 
leading to lateral recumbency in severe cases. Two birds out of 9 in Inoc6 exhibited clinical 223 
signs 6 days after inoculation, but did not die before the end of the experiment. Eight turkeys 224 
out of 10 in Inoc7 presented clinical signs, which appeared between 3 and 6 days after 225 
inoculation. Among them, only 3 animals died at day 5. In set B, an acute respiratory 226 
distress was registered between 1 and 3 days post inoculation of A. fumigatus in all turkeys 227 
of Inoc8 (n=10), which died 24 to 48h later (figure 2). 228 
3.2. Macroscopic and microscopic lesions 229 
No macroscopic lesions were observed on non-challenged and Inoc5 birds. An increasing 230 
proportion of turkeys from Inoc6 (5/10), Inoc7 (8/10) and Inoc8 (10/10) exhibited few 231 
granulomas on thoracic air sacs and a densification of variable proportions of the pulmonary 232 
parenchyma. Histological lesions associated with Aspergillus development, mostly 233 
represented by multifocal either isolated or coalescing granulomas with necrotic centers, and 234 
occurrence of multinucleated giant cells (figure 3) were confirmed in lungs of Inoc6, Inoc7 235 
and Inoc8 turkeys but were absent in Inoc5 or non-challenged birds. Percentages of altered 236 
parenchyma varying from 30 to 80% have been estimated on lungs preparation coming from 237 
different birds belonging to Inoc7 and Inoc8. However, the hyphae burden seemed to be 238 
more important in the latter group. 239 
 240 
3.3. Fungal cultures from trachea, air sacs and lungs 241 
The lower limit of the assay is approximately 300 CFU/g of lung (10 CFU/plate). All non-242 
challenged turkeys exhibited negative cultures. Semi-quantitative numerations from trachea 243 
and air sacs showed variable levels of contamination immediately after inoculation in all 244 
challenged groups. However no Aspergillus could be recovered from both organs of all birds 245 
of Inoc5, Inoc6 and Inoc7 that were euthanized between 5 and 8 days post challenge. For 246 
Inoc8, a high level of contamination (>100 CFU/plate) was still present in air sacs till day 4, 247 
but not in trachea even in turkeys which died spontaneously 2 days after inoculation. 248 
Positive counts ranging from 3.28 up to 9.75 log10 CFU/g have been registered on lungs of 249 
all turkeys sacrificed immediately after the inoculation.  In the remaining birds, the 250 
proportion of positive samples and the mean of log CFU/g of lung established on those 251 
samples increased with the inoculum size (table 1). The mean of log10 CFU/g of lung for the 252 
13 turkeys (Inoc7 and Inoc8) that died spontaneously between 2 and 5 days pi was 5.47 ± 253 
0,41. 254 
 255 
3.4. Assessment of conidial equivalent by real time PCR 256 
The sensitivity of real time PCR on 28S target was higher than on FKS gene with limits of 257 
detection varying from 5 CE (corresponding to 103 CE/g of lung) to 250 CE per reaction (5 x 258 
104 CE/g of lung) respectively. Immediately after experimental infection, qPCR signals 259 
remained undetectable for the 2 birds of Inoc5, one turkey of Inoc6 but highly positive for 260 
the others (Inoc7 and 8). At day 8, no amplification at all was detected with both targets for 261 
Inoc5 and only 3/9 samples from Inoc6 were detected with the 28S target. The numbers of 262 
CE/g established of lung detected with FKS target and 28S target were positively correlated 263 
(log10 CEFKS/g of lung = -2.92 + 1.34*log10 CE28S/g of lung) when assessed on the 17 DNA 264 
samples (7/10 Inoc7 and 10/10 Inoc8) exhibiting amplification with both DNA targets (data 265 
not shown). Similarly to fungal numerations both proportions of positive amplifications and 266 
means of log CE28S/g of lung in positive results appeared to be correlated to the inoculum 267 
size (table 1). 268 
 269 
3.5. Galactomannan (GM) quantity assessment 270 
GM index obtained on crude lung homogenates presented huge variations from 0.5 to 6 271 
(signal saturation) in all groups including non-challenged birds. GM index repartition after 272 
1:100 dilution (figure 4) was quite similar in control, Inoc5 and Inoc6 birds (p=0.0084). The 273 
highest variation of GM index values was observed in Inoc7 (mean GM index = 3.99 ± 274 
0.90). All turkeys that died spontaneously (including all Inoc8) exhibited index higher than 275 
5. Interestingly, GM index of all birds immediately euthanized after inoculation were lower 276 
than 0.35. 277 
3.6. Correlation between the different markers 278 
The number of log10 CE28S/g of lung was strongly correlated to the number of log10 CFU/g 279 
of lung (p<0.0001) when the data of all groups were included (figure 5) but not in each 280 
groups considered separately. Both values increased significantly with inoculum size 281 
(p<0.0001). As featured by the regression line, the sensitivity threshold of CE values was 282 
almost 10 fold higher than CFU counts in lung samples (log10 CE28S/g of lung = 1.30*log10 283 
CFU/g of lung). Birds, which died quickly, have constantly more CFU and CE in lungs than 284 
the other birds. GM index applied to diluted lung homogenates (1:1000) of Inoc8 was 285 
significantly correlated to log10 CE/g (p=0.0172) but not with log10 CFU/g (p=0.526) (figure 286 
6). 287 
 288 
3.7. Environmental contamination 289 
Negligible levels of contamination by molds (Aspergillus spp. and Mucorales) have been 290 
detected in the litter or in the room’s atmosphere prior to the installation of the birds or after 291 
inoculation (controls at day 1 and day 8). Feedstuffs remained constantly culture-negative. 292 
 293 
3.8. Molecular typing of A. fumigatus  294 
 Six A. fumigatus isolates collected from the animals and the environment presented the 295 
same MLVA genotype as that of the reference strain (CBS 144.89) used for the 296 
experimental infection. 297 
 298 
 299 
 300 
 301 
4. Discussion 302 
4.1. Experimental model 303 
Many experimental aspergillosis have already been published using different avian models 304 
and testing various bird species, age at inoculation, challenge routes and even the 305 
Aspergillus species [1]. Both field data [2] and experimental results [26] clearly demonstrate 306 
a higher susceptibility of turkeys and quails to A. fumigatus infection when compared to 307 
chickens, but also intraspecific differences in host responses [4, 27] highlighting the 308 
necessity to establish models on relevant species or lineages reared for meat or egg 309 
production. Different routes of Aspergillus inoculation have been tested in turkeys including 310 
intrapulmonary [28], intra-air-sac administration [11, 21] and finally aerosolization in 311 
confined plastic chambers [3]. With the exception of the latter method, which is difficult to 312 
standardize [4], the intratracheal inoculation, which has not been yet tested in turkeys, is the 313 
closest to the natural way of infection and only bypasses the upper airways and their putative 314 
defenses [1]. We propose a relevant model of acute aspergillosis in one-week-old turkeys 315 
following intratracheal nebulization of Aspergillus fumigatus conidia with a MicroSprayer® 316 
aerosolizer. The use of this device has already been validated in immunosuppressed 6-8 317 
weeks-old Sprague-Dawley rats [16] and immunocompetent Japanese quail [7] to 318 
administrate precisely calibrated inoculum of Aspergillus fumigatus in the respiratory tract. 319 
The evaluation of the impact of four inoculum concentrations (105 to 108 conidia per turkey) 320 
allowed us to record mortality following a dose response with values of 0, 0, 30 and 100% 321 
respectively. Global parameters such as the evolution of body-weight, the occurrence and 322 
severity of clinical signs and the chronology of deaths appeared strictly in concordance with 323 
the concentration of conidia administered. Lower mortality rates (respectively 16, 55, 56 and 324 
20%) have been observed in turkeys treated with 108 conidia in the air sac [21] or submitted 325 
to dry aerosol delivering doses of 5.109 spores per animal [3] or in quails receiving 1.5 106 326 
[9] conidia intratracheally. A similar protocol (2.107 conidia administered intratracheally) 327 
applied to the same species resulted in 55% [29] and 100% mortality [8].  As mentioned by 328 
Goetting et al. [7] who compared two modalities of inoculation, the nebulization by 329 
Microsprayer® should not be considered to be strictly equivalent to a “classical” 330 
intratracheal inoculation using an intravenous catheter after removing the stylet. Higher 331 
mortality (88% versus 33%) has indeed been observed after nebulization compared to the 332 
“classical” method after the same inoculum size (4.7 107 spores). This could be attributed to 333 
differences in dispersion parameters (velocity, dropplet size) through the respiratory tract. 334 
Similarly to [7], the macroscopic lesions registered in our model were strictly limited to the 335 
respiratory apparatus and particularly marked in lungs but much more rarely on caudal air 336 
sacs. Extensive parenchyma necrotic damage consecutive with the presence of multifocal 337 
typical granulomas [11, 13] were seen in the present experiment in all birds of Inoc8 but also 338 
in some animals belonging to Inoc7, which have been euthanized at the end of our 339 
experiment. We cannot therefore exclude the possibility of delayed mortality (up to 50%) in 340 
the latter group if the experiment took place over a longer post-inoculation period [3]. 341 
 342 
4.2. Biomarker evaluation 343 
The relevance of three putative biomarkers (CFU, galactomannan and real-time PCR) has 344 
been concomitantly assessed on lung homogenates for the first time in turkeys. In contrast 345 
with already published models in the immunosuppressed rat [15] or Guinea pig [17, 18], our 346 
primary purpose was to study the kinetics of fungal development in several target organs but 347 
to compare the effect of variable inoculum sizes on these parameters and, in addition, we 348 
tried to establish potential correlations to characterize fungal burden states in the lung since 349 
it was the sole organ to present extensive macroscopic lesions in our model. 350 
Semi-quantitative culture-based methods used to evaluate the Aspergillus load in organs are 351 
easy to perform and common but only detect viable organisms. Furthermore, temporal 352 
studies in rodents suggest that these tools may not be accurate when monitoring the 353 
development of multicellular filamentous fungi particularly in parenchyma submitted to 354 
mechanical homogenization [30] leading to possible underestimation [31, 32]. Except for 355 
some air sacs samples obtained from turkeys, which died in the first four days following 356 
inoculation, no fungus could be detected on the trachea or air sac swabs. This may be 357 
explained by fungal clearance, or low sensitivity of the method used on these organs. 358 
Although not strictly comparable because the interval post-inoculation differed between 359 
dead and euthanized birds, the mean lung numerations, the proportion and the homogeneity 360 
of positive results seemed clearly to increase with the inoculum dose. All dead animals 361 
presented at least 5.105 spores/g of lung tissue which was estimated by Richard et al. [3] as 362 
the dose necessary to kill about 50% of 3-week-old turkeys exposed to an aerosol of 363 
Aspergillus conidia which appeared to be a clear threshold in younger birds unable to mount 364 
an effective innate response [4, 11, 13] in the critical phase of the first days following 365 
experimental infection. The detection of viable Aspergillus was possible in a high proportion 366 
of apparently healthy turkeys, which were euthanized at the end of the experiment, but may 367 
persist to least 8 weeks post-exposure [3]. However, fungal load in surviving birds as 368 
assessed by culture seemed to decrease post-inoculation as in other avian [4, 9] or mammal 369 
models [18, 19]. 370 
The enzyme immune assay of galactomannan, a specific cell-wall component of fungi is 371 
relatively easy to perform and is likely to reflect the progressive increase in mycelium load 372 
by tip extension of hyphae [31]. The availability of commercial tests has allowed this 373 
polysaccharide component to be measured as a valuable biomarker in the sera of different 374 
bird species suffering from aspergillosis [20]. It has been used in field studies on 375 
commercial broiler chickens and turkeys [22], but also in mammals [16, 32] and turkeys 376 
[21] experimental models. As a potential diagnosis tool, contrasting results have been 377 
obtained due to variable sensitivity or specificity depending on the species tested. Additional 378 
difficulties exist in the definition of an appropriate cut-off value and the stage of the disease 379 
[20] but also to the ubiquitous presence of galactomannan in the poultry environment 380 
leading to false positives [1]. This last point may partially explain the positive GM values 381 
obtained from crude lung homogenates of control birds housed in a clean but not sterile 382 
environment. This necessitates work on dilutions to evaluate this parameter. The GM index 383 
on 1:100 dilutions were very low in turkeys submitted to the two lowest doses as for non-384 
exposed birds but were much more variable in Inoc7. This may reflect individual differences 385 
in host-response efficiency. The high GM index systematically seen in turkeys, which died 386 
spontaneously in contrast to almost undetectable values in birds euthanized immediately 387 
after receiving variable doses of non-germinated conidia, is consistent with the relationship 388 
between the index value and the progression of the fungus [17, 31]. Furthermore, GM index 389 
correlated with the extent of infection as demonstrated by histopathological examination 390 
[18]. 391 
A real-time quantitative PCR assay has been developed recently in rodent models to 392 
measure the fungal load and its progression in different organs in order to evaluate the 393 
efficacy of antifungal therapy [15, 17, 18, 19]. This molecular tool allows the detection of 394 
both conidia and hyphae and can be very sensitive and specific but like the GM enzyme 395 
immunoassay, it does not indicate viability [31]. Gene targets included a monocopy gene 396 
like FKS1 [18] or multicopy genes, in particular the ribosomal DNA genes [15] and internal 397 
transcribed spacer. The choice of multicopy genes alone or in the frame of a nested PCR 398 
[17] to improve sensitivity may not be ideal for standardization of the method [32]. To our 399 
knowledge, qPCR in avian lungs was evaluated for the first time in this study. The real-time 400 
PCR signal from a sample of infected tissue was compared with a standard curve composed 401 
of conidia added to naïve pulmonary parenchyma and we chose to express the fungal 402 
biomass in terms of CE [15]. The performances of the monocopy FKS gene and the 403 
multicopy 28SrDNA amplification in turkey lungs proved to be equivalent although the 404 
sensitivity of the latter PCR was logically about 1 log10CE/g lower. Mathematical 405 
extrapolation predicted that the detection limit of this assay was approximately 103 CE/g of 406 
lung, which is quite similar to 2.103 CE/g (18S) estimated in an haematogenous mouse 407 
model of aspergillosis [15], but could further be improved with a nested qPCR [17]. As 408 
demonstrated by results on euthanized birds just after inoculation, the qPCR seemed to be 409 
less sensitive than CFU numerations, which may be explained by a low efficiency of 410 
extraction of conidia from tissue samples [19, 30]. Although no signal could be amplified in 411 
Inoc5 and there was no sign of illness, both the proportion of positive samples and mean 412 
log10CE/g tended to increase with the dose used. Finally, the onset of induced mortality 413 
coincided clearly with a peak in fungal burden in Inoc8 as observed in a mouse model [15]. 414 
A strong correlation between qPCR results and culture numerations was seen when positive 415 
data from all groups were included and the molecular method demonstrated a higher 416 
sensitivity. This relationship appears to be stronger when tissues contain hyphae rather than 417 
conidia [30]. When data from Inoc8 were compared with similar mammal models [15, 18], 418 
GM index and qPCR appeared to be more closely correlated with the rise of infection in 419 
comparison with CFU values which may partially be explained by the fact that the culture-420 
numerations stagnates or decreases with time [19].  421 
 422 
4.3. Conclusion 423 
We have developed a repeatable and standardized model of acute and fatal primary 424 
pulmonary pneumonia in the young, immunocompetent turkey using an atomizer, which 425 
may be applicable to chemotherapy trials. Housing birds in groups in a controlled 426 
environment enables field conditions of production to be mimicked and to evaluate the 427 
treatment of aspergillosis by nebulized molecules such as azole compounds [2]. Besides 428 
survival, still considered the most reliable measure to assess antifungal therapy, the 429 
combination of additional markers of fungal development may contribute to an earlier and 430 
more precise detection of treatment efficiency in birds submitted to lethal or sub-lethal 431 
challenges but also to the refinement and the reduction objectives of in vivo experimental 432 
research [31, 32]. 433 
 434 
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Table 1. Fungal burdens in lungs of inoculated turkeys measured by CFU and real time PCR 439 
(28S) assays.  440 
Groups
Inoc5
Inoc6
Inoc7
Inoc8
5.73 ± 0.14 (7/10)
7.17 ± 0.11 (10/10)
4.34 ± 0.29 (7/10)
5.60 ± 0.12 (10/10)
BLDa BLD
Mean log10 CFU/g of lung Mean log10 CE28S /g of lung
2.84 ± 0.30 (5/9)b 5.32 ± 0.13 (3/9)
a BLD : below level of detection
b
 Mean ± standard error (no. of positive values/total no. of birds tested)
 441 
 442 
Figure 1. Mean weight variations of inoculated birds (black line) compared to non-443 
challenged turkeys (grey line) from set A (solid line) or B (dashed line). Inoculum of 105 444 
(), 106 (), 107 () or 108 () Aspergillus fumigatus conidia.  445 
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 448 
Figure 2. Survival time of non-challenged (grey line) and inoculated (black line) turkeys 449 
from set A (solid line) and B (dashed line) Inoculum of 105 (), 106 (), 107 () or 108 450 
() Aspergillus fumigatus conidia.  451 
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 459 
 460 
Figure 3. Histological sections of lungs from 2 turkeys (Inoc8). 3a (HES stain): Voluminous 461 
granuloma with a necrotic centre. 3b, 3c (HES stain) and 3d (MS stain): Detailed of a 462 
granuloma. A: necrosis; B: granuloma; C: red blood cells in capillary; D: giant cells with 463 
multiple nuclei; E: Aspergillus hyphae. 464 
 465 
 466 
Figure 4. Comparison of mean Galactomannan index (1:100 dilution) in lung samples from 467 
non challenged and inoculated groups. 468 
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 478 
 479 
Figure 5. Relationship between CFU and CE (log10 CE28S/g of lung = 1.30*log10 CFU/g of 480 
lung) as shown by linear regression. Turkeys inoculated with 105 (), 106 (), 107 () or  481 
108 () conidia. *Significant correlation (p < 0.0001) between results by the Spearman rank 482 
correlation, n = 21. 483 
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 491 
 492 
Figure 6. Relationship between GM index and CFU (A) or CE (B) per g of lung from 493 
turkeys inoculated with 108 conidia. *Significant correlation (p = 0.0038) between 494 
galactomannan index and CE by the Spearman rank correlation test, n = 10. 495 
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